The Mycobacterium bovis BCG vaccine is the only tuberculosis (TB) vaccine available, yet it provides limited protection against pulmonary TB in adults and fails to protect against TB reactivation. We hypothesized that immunity against Mycobacterium tuberculosis (Mtb) "resuscitation-promoting factors" (Rpfs), which are small bacterial proteins that promote proliferation of dormant mycobacteria, may be relevant in the human immune response to Mtb. In previous unpublished work, we found that Rpfs Rv0867c and Rv2389c induced interferon gamma (IFN-γ) production in the blood of TB patients' healthy household contacts in several different African populations. Here we examine these two dominant Rpf antigens in more detail and define the nature of the responding T-cell subsets. Multiparameter cytokine profiling showed that Rv2389c and, to a lesser extent, Rv0867c were recognized by mycobacterium-responsive healthy Dutch individuals; peptide-scanning revealed several epitopes, including a single immunodominant epitope in Rv2389c. Rv0867c and, to a lesser extent, Rv2389c Rpf-specific T-cell responses were maintained for decades in long-term Mtb non-progressors. Prominent Rv0867c-specific double-and single-cytokine-producing CD8 + T-cell subset responses were found, including a large population of CD8 + effector memory and effector T-cell subsets. We conclude that Mtb Rpf antigens are important targets in the human immune response to Mtb, and represent interesting TB vaccine candidate antigens.
Introduction
It is estimated that over 2 billion people are latently infected with Mycobacterium tuberculosis (Mtb) and that 5 to 10% of these individuals will develop active tuberculosis (TB) at one point in their lifetime whereas the remainder are able to contain infection long term without developing clinical symptoms [1] . During latency, the bacteria are thought to be in a dormant or slowly replicating state [2] . The vast reservoir of individuals with latent infection is a major source of new TB cases due to reactivation and resuscitation of dormant bacilli [3;4] .
The term "dormancy" was first introduced by Joseph Warwick Bigger, who discovered that a culture of Staphylococcus pyogenes could not be sterilized after penicillin treatment since there was a small group of antibiotic-resistant bacteria that could be re-grown from such cultures. Bigger proposed that these bacteria were dormant, nonreplicating, and thus insensitive to antimicrobials targeting bacterial metabolic pathways [5] .
It is assumed that environmental factors are involved in inducing bacterial dormancy [6] . Mtb enters a state of nonreplicating or slowly replicating persistence when grown under gradual oxygen depletion, which is thought to be one of the stress factors that Mtb encounters upon infection [7] . Not only oxygen deprivation, but also low pH, NO, nutrient deprivation and host immune pressure are stress factors Mtb is subjected to in the lung granulomatous lesions. In response to these stress factors, Mtb decreases its metabolic activity and alters its gene expression pattern [6;8;9] . This adaptation results in increased resistance to environmental stress, by means of entering the nonreplicating or slowly replicating persisting state [10] .
While several studies have addressed bacterial transition from the replicating to the nonreplicating, slowly replicating or dormant state, little is known regarding the cues that induce bacteria to reactivate and resume growth from dormancy. Mukamolova et al. were the first to discover a resuscitation promoting factor (Rpf), a hormone-like protein secreted by Micrococcus luteus (M. luteus). Addition of this Rpf protein to dormant M. luteus resulted in resuscitation of M. luteus bacteria [11;12] . Rpf genes were then found to be conserved throughout high-G+C Grampositive bacteria, including Mtb. Five such genes were identified in the Mtb genome, notably Rv0867c (rpfA), Rv1009 (rpfB), Rv1884c (rpfC), Rv2389c (rpfD) and Rv2450c (rpfE). Each Mtb Rpf protein contains an ~70 amino-acid rpf-like domain similar to the M. luteus rpf-encoded protein [13] . Mtb Rpfs showed similar properties to M. luteus Rpf, including their ability to resuscitate dormant mycobacteria [13;14] . Mtb Rpf protein expression was observed in vitro in actively growing Mtb and in Mycobacterium bovis Bacillus Calmette-Guérin (BCG). Importantly, Mtb rpf gene expression was detected in infected murine and human tissue. Moreover, the presence of Rpf-like proteins was shown in Mtb-infected human tissue [13;15-17] . Recently, rpf gene expression was analyzed in Mtb cells grown under different physiological stress conditions and growth factors. All five rpf genes were expressed during actively replicating early log-phase growth of Mtb, confirming previous findings. Of note, Mtb rpf genes displayed differential expression patterns when analyzed in cultures grown under hypoxia, nutrient starvation and acidic conditions and stationary-, nonculturable-, and resuscitation-phase-like conditions. These differential adaptive rpf expression profiles indicate that Mtb Rpfs likely play different roles [4] .
While M. luteus Rpf is essential for M. luteus growth, individual Mtb Rpfs were found to be redundant for growth in vitro and in vivo in single-gene-knockout mutants [17;18] . However, when multiple rpf deletions were introduced simultaneously in Mtb (∆Rv0867c/∆Rv1009/∆Rv1884c and ∆Rv0867c/∆Rv1009/∆Rv2389c), a significant loss in the ability of Mtb to resuscitate was found, accompanied by in vitro growth attenuation [19] .
BCG vaccination is widely used and affords protection from severe forms of TB in children, but it provides only limited and highly variable protection against pulmonary TB in adults and does not protect against reactivation. Better TB vaccines are clearly needed [20] . As the Mtb Rpf proteins are associated with resuscitation of mycobacteria, we hypothesized that immunity directed against these proteins may play a role in sensing actively replicating Mtb organisms and possibly play a role in host immune control of reactivating bacteria. Only two reports have investigated the immunogenicity of the Mtb Rpf antigens. One study with mice showed that Rv0867c, Rv1009, Rv2389c and Rv2450c were immunogenic [21] . Recently we identified the first human Mtb Rpfspecific T-cell responses against a subset of the five Mtb Rpfs in a larger antigen T-cell screening [22] . Interferon gamma (IFN-γ) production was detected in tuberculin skin test (TST)-positive individuals in response to Rv1009, Rv1884c and Rv2450c and, to a lesser extent, to Rv0867c, whereas limited to no IFN-γ was found in TST-negative individuals. Rv2389c, however, was not included in this study [22] . These two studies indicate a possible role for T-cell responses in detecting Mtb Rpf antigen during Mtb infection. We have, therefore, performed a more detailed analysis studying the immunogenicity of the Rv0867c and Rv2389c Mtb Rpf proteins in several groups of mycobacteriaexposed individuals, including long-term non-progressors. These two antigens were selected based on highest recognition of all 5 rpfs in a cross-sectional cohort study of HIV-negative, TST-and/ or ESAT6/CFP10-positive household contacts from the Gambia, Uganda, and South Africa (BMGF GCGH GC6#74 Biomarkers for TB consortium; http://www.biomarkers-for-tb.net/; unpublished results). Of interest, both Rv0867c and Rv2389c are predicted to be secreted proteins (SignalP and TMMHM server Technical University of Denmark) [23] , which may enhance availability of the antigen to the innate immune system. Indeed, Rv0867c protein is present in Mtb culture filtrate [24] . Rv0867c and Rv2389c are both expressed in early log-phase-grown Mtb, but Rv2389c expression is induced in stationary and noncultivatable phases of Mtb and during acidic conditions, whereas Rv0867c expression appears to be higher in nutrient-starved Mtb culture. Both genes are also highly induced during early resuscitation [4] . In the work reported here, we (i) identify frequent and significant human T-cell responses against Rv0867c and Rv2389c; (ii) identify a series of novel Mtb rpf epitopes, including a single dominant peptide epitope in Rv2389c; and (iii) describe Mtb rpf-specific polyfunctional memory CD4 + and particularly CD8 + T-cell memory responses to Rv0867c and Rv2389c Mtb rpf proteins in long-term naturally protected, Mtb nonprogressors. Based on these data, we propose that rpf antigens are potentially interesting new TB vaccine candidates.
Materials and methods
Study subjects. Blood samples were collected by venipuncture from a group of Dutch individuals including 9 tuberculosis (TB) patients, 10 tuberculin skin test (TST)-positive individuals (indurations of ≥ 10 mm), 10 BCG-vaccinated individuals and 10 non-BCG-vaccinated, TST-negative, healthy individuals, as well as 12 Norwegian TST-positive individuals. The Norwegian donor group consisted of elderly people (average 70 years) exposed to TB transmission several decades ago without developing any clinical disease and without receiving any treatment. Previously recorded TST indurations associated with natural conversion ranged from 12 to 60 mm (average 18 mm). Recent Interferon gamma (IFN-γ) release assay (IGRA) testing with the Quantiferon Gold in-tube test showed that 9 of 12 donors in this category were positive. All donors gave written consent before blood donation. The study protocol (P207/99) was approved by the Institutional Review Board of the Leiden University Medical Center and the Regional Committees for Medical and Health Research Ethics in Norway. Peripheral blood mononuclear cells (PBMCs) were isolated from heparinized venous blood by Ficoll density gradient centrifugation and stored in liquid nitrogen until further use.
Recombinant proteins.
Recombinant proteins were produced as previously described [25] . Briefly, Mtb genes were amplified by PCR from genomic H37Rv DNA and cloned by Gateway technology (Invitrogen, Carlsbad, CA, USA) in a bacterial expression vector containing a histidine tag at the N-terminus. Vectors were over-expressed in Escherichia coli BL21(DE3) and purified. The size and purity of recombinant proteins were analyzed by gel electrophoresis and Western blotting with an anti-His antibody (Invitrogen, Carlsbad, CA, USA) and an anti-E. coli polyclonal antibody (a kind gift from the Statens Serum Institute (SSI)). Endotoxin contents were below 50 IU/mg recombinant protein, as tested using a Limulus Amebocyte Lysate (LAL) assay (Cambrex, East Rutherford, NJ). All proteins were tested in lymphocyte stimulation assays in order to exclude antigen-nonspecific T-cell stimulation and cellular toxicity by using PBMCs of in vitro purified protein derivative (PPD)-negative healthy Dutch donors [26] . PPD of M. tuberculosis was purchased from SSI, Copenhagen, Denmark.
Synthetic peptides. Peptides (20-mers overlapping 10 amino acids) were produced at the Leiden University Medical Center (LUMC) facility by simultaneous multiple-peptide synthesis as described previously [27] . Homogeneity and purity were confirmed by analytical reversedphase high-pressure liquid chromatography, and mass spectrometry showed the expected masses. Peptide purity was ≥ 75%.
Lymphocyte stimulation assay. PBMCs (1.5×10 5 / well) were cultured in triplicate in 96-wells round-bottom plates (Nunc, Roskilde, Denmark) and incubated with or without protein (10 μg/ ml) in AIM-V medium (Invitrogen, Breda, The Netherlands) at 37°C, 5% CO 2 . After 6 days supernatants were harvested and used for cytokine and chemokine profiling.
Cytokine and chemokine profiling. Levels of cytokines (IFN-γ, interleukin-1β (IL-1β), interleukin-6 (IL-6) and tumor necrosis factor alpha (TNF-α)) were analyzed using the Lincoplex ® kit (Millipore) according to the Milliplex™ Map protocol. Plates were analyzed using a BioPlex array reader with Bio-Plex software (Bio-Rad Laboratories, Veenendaal, The Netherlands).
Generation of antigen-specific T-cell lines.
T-cell lines were generated as previously described [28] . PBMCs (2x10 6 cells/well) from cured TB patients or TST-positive or BCGvaccinated individuals were cultured in 24-well plates in the presence of protein (2 to 10 μg/ ml) in IMDM medium (Gibco, Paisley, UK) supplemented with 50 U/ml penicillin, 50 μg/ml streptomycin (Gibco, Paisley, UK) and 10% pooled human serum at 37 °C, 5% CO 2 . At day 6, recombinant-interleukin-2 (rIL-2) (Cetus, Emeryville, CA, USA) was added to the cell cultures in a final concentration of 25 U/ml. Cultures were maintained for an additional 2 to 3 weeks in the presence of rIL-2. T cells were harvested and stored in liquid nitrogen until further use.
T-cell proliferation of antigen-specific T-cell lines.
Thawed T-cell lines were cultured in triplicate in 96-wells flat-bottom plates (1.5×10 4 /well) together with HLA-DR-matched irradiated (2000 rad) PBMCs (5×10 4 /well) with or without protein (10 μg/ml) or peptide (10 μg/ml) at 37 °C 5% CO 2 . After 3 days, supernatants were harvested and stored at -20 °C. Cells were pulsed for an additional 18 hours with [ 3 H]thymidine (0.5 µCi/well), harvested, and counted on a Microbetaplate counter (Wallac Turku, Finland) [29] . A stimulation index (SI) of ≥ 3 was considered positive.
IFN-g ELISA. The concentration IFN-g in supernatants was measured by enzyme-linked immunosorbent assay (ELISA) (U-CyTech, Utrecht, The Netherlands) according to the manufacturer's instructions. The detection limit of the assay was 20 pg/ml IFN-γ. Samples were tested in duplicate. An IFN-g response ≥ 100 pg/ml was considered positive.
Flow cytometric analysis.
PBMCs were thawed and rested. After 24 hours, PBMCs were stimulated for 16 hours with protein (10 μg/ml) in the presence of co-stimulatory antibodies anti-CD28 and anti-CD49d (Sanquin, Netherlands and BD Biosciences, respectively). Brefeldin A (3 μg/ml; Sigma) was added after the first 4 to 6 hours. Cells were stained for 30 minutes at 4 °C using the following surface markers; anti-CD3-Pacific blue (PB), anti-CD4-peridinin chlorophyll protein (PercP)-Cy5.5, anti-CD8-AmCyan, anti-CD25-allophycocyanin (APC)-Cy5, anti-CD45RAphycoerythrin (PE)-Cy5 and anti-CCR7-PE/Cy7 and intracellular staining was performed with anti-IFN-γ-Alexa 700, anti-TNF-α-APC, anti-IL-2-PE and anti-CD69-fluorescein isothiocyanate (FITC) (BD Biosciences) by using the Intrastain kit (Dako Cytomation, Denmark). Samples were acquired on an LSR II flow cytometer and analyzed using SPICE (software provided by Dr. M. Roederer, National Institute of Allergy and Infectious Disease) and FlowJo software (Treestar Inc, Ashland, OR, USA). Cell populations should contain at least 100 events.
Statistical analyses. Differences between groups were analyzed with the non-parametrical
Kruskal-Wallis test in GraphPad Prism (version 4). P values were corrected for multiple comparisons. The statistical significance level used was P <0.05.
Results

Recognition of Mtb Rpf antigens by T cells from Mtb-responsive individuals
To determine the immunogenicities of both Rv0867c and Rv2389c, we investigated whether these two Mtb Rpf proteins were recognized by PBMCs of mycobacterium-exposed individuals. PBMCs from four groups of Dutch individuals were tested: (i) HIV-negative, treated tuberculosis patients (TB; n = 9); (ii) tuberculin skin test (TST)-positive individuals (TST; n = 10); (iii) BCGvaccinated individuals (BCG; n = 10); and (iv) non-BCG-vaccinated, TST-negative and in vitro purified-protein-derivative (PPD)-negative healthy controls (HCs; n = 10). The secretion of four cytokines (IFN-γ, IL1-β, IL-6 and TNF-α) was analyzed as a multiparameter read out of antigenspecific responses.
As expected, IFN-γ production in response to PPD was low in healthy individuals, whereas the TST + individuals and TB patients showed high responses to PPD, by both IFN-γ and the other cytokines analyzed. The BCG-vaccinated individuals showed intermediate levels of responses ( Figure 1A to D).
While minor IFN-γ levels were detectable in the three mycobacterium-exposed groups in response to Rv0867c, higher levels were found in response to Rv2389c (HCs and BCG; P < 0.05). The healthy controls did not respond to Rv0867c and Rv2389c ( Figure 1A) . No IL-1β was produced upon Rv0867c stimulation in any of the four groups analyzed; however, Rv2389c stimulation induced production of IL-1β in all mycobacterium-exposed groups (HCs and TB; P < 0.05), but not in the healthy controls ( Figure 1B ). Rv0867c stimulation also induced IL-6 in all three mycobacterium-exposed groups, but not in the healthy individuals (HCs, TST, and TB P < 0.05). In contrast to Rv0867c, Rv2389c induced high levels of IL-6 in the HC group but much higher levels in the mycobacterium-exposed individuals (HCs and TB; P < 0.05) ( Figure 1C ). Rv2389c stimulation induced also high levels of TNF-α, especially within the mycobacteriumexposed groups (HCs and TB P < 0.05), while Rv0867c induced only limited levels of TNF-α in all four groups ( Figure 1D ). Overall, the mycobacterium-exposed individuals produced the highest levels of cytokines upon Rv0867c and Rv2389c stimulation, and TB patients were often the highest responders to Rv2389c (HCs and TB; P < 0.05 for IL-1β, IL-6 and TNF-α). Rv2389c was more strongly recognized than Rv0867c, which induced no or low levels of cytokines.
Identification of immunogenic peptides of Mtb Rpf proteins
To further characterize the Rpf-specific responses observed above, five CD4 + T-cell lines specific for Rv0867c and five CD4 + T-cell lines specific for Rv2389c were generated. These T-cell lines were tested for recognition of all individual 20-mer peptides (overlapping by 10 amino acids) (see Supplementary Table S1A and B) and both IFN-γ production and T-cell proliferation were measured. Table 1 shows the recognition pattern of the Rpf peptides by the Rv0867c and Rv2389c antigen-specific T-cell lines examined. All T-cell lines responded to the corresponding Rpf protein and to one or more of the proteins' corresponding individual peptides. The Rv0867c-specific T-cell lines recognized many different peptides ranging from 1/5 to 4/5 of the donors. Four out of the five T-cell lines recognized peptides P5 [41] [42] [43] [44] [45] [46] [47] [48] [49] [50] [51] [52] [53] [54] [55] [56] [57] [58] [59] [60] and P10 91-110 and three of the five lines recognized peptide P7 61-80 . In contrast to Rv0867c-specific T cells, all Rv2389c-specific T-cell lines recognized only a single peptide, P12 111-130 . 
Characterization of Mtb Rpf-specific polyfunctional T cells in long-term Mtb nonprogressors
We next investigated T-cell responses to Rv0867c and Rv2389c antigens in a cohort of longterm Mtb non-progressors, which had been infected several decades ago but had never developed any signs of active TB. We analyzed responsive CD4 + and CD8 + T-cell subsets producing IFN-γ, TNF-α and/or IL-2 by multiparameter flow cytometry. Polyfunctional T cells have been associated with protection following vaccination [30] , but the situation in human infection is more complex, as polyfunctional T cells are also found in active TB patients [3] . In any case, the memory T-cell subsets responding to Rv0867c or Rv2389c was analyzed using PBMCs from longterm nonprogressors (n = 12) and PPD-negative HCs (n = 11). Figure 2A shows that the Rv0867c protein induced polyfunctional T cells with different cytokine profiles (triple-positive (IFN-γ + TNF-α + IL-2 + ) or double-positive (IFN-γ + TNFα + , TNFα + IL-2 + and IFN-γ + IL-2 + ) cells). Such polyfunctional T cells were detected in 9 out of the 12 long-term latently infected individuals. Strikingly, higher frequencies of polyfunctional CD8 + T cells (ranging between 0.20 and 9.72%) were observed, exceeding those of CD4 + T cells (ranging between 0.21 and 1.29%). Only 2 out of 12 donors showed polyfunctional CD8 + T cells recognizing Rv2389c, typically with a lower frequency (ranging between 0.24 and 0.82%) ( Figure 2C ). Single-cytokineproducing CD4 + and CD8 + T cells were observed for both Rv0867c and Rv2389c, where IFN-γ + CD4 + T cells are the most prominent T-cell subset of all single-cytokine-producing T cells. No polyfunctional T cells were induced within the negative healthy control population upon Rv0867c stimulation, although for unknown reasons, low numbers of IL-2 + single-positive cells were seen ( Figure 2B) . Some low frequencies of polyfunctional and single-positive T cells were observed upon Rv2389c stimulation within the healthy control group ( Figure 2D ), but lower than those in the latently infected group. Figure 2E shows the proportions of polyfunctional and single-positive CD4 + and CD8 + T cells for Rv0867c, as this antigen was the best recognized in this cohort. IFN-γ + TNF-α + doublecytokine-producing CD8 + polyfunctional T cells were the most prominent polyfunctional T-cell subset identified.
In addition, we analyzed the expression of the T-cell memory markers CCR7 and CD45RA in these IFN-γ + TNF-α + double-cytokine-producing CD8 + T cells in the Rv0867c responders. After dividing the responding T-cells into central memory (Tcm) and effector memory (Tem) T-cell subsets (according to Seder et al. [31; 32] ), we found that Rv0867c-responding IFN-γ + TNFα + CD8 + T cells consisted mostly of effector memory (CCR7and CD45RA -) and effector (Teff) (CCR7and CD45RA + ) T-cell subsets ( Figure 2F) . These data show the presence of Rv0867c-specific CD8 + memory and effector T cells in long-term Mtb non-progressors.
Figure 2. Frequency of antigen-specific polyfunctional T cells in long-term Mtb nonprogressors.
Shown is the frequency of antigen-specific CD4 + and CD8 + T cells in long-term latently infected elderly subjects (n = 12), producing combinations of IFN-γ, TNF-α and IL-2 after stimulation for 16 hours with Besides the quantity of the T-cell response, the quality of the T-cell response plays an important role in protection. We therefore also measured the median fluorescence intensity (MFI) of each cytokine produced by the Rv0867c-responsive T cells. Multiplication of the frequency by the MFI results in an integrated MFI (iMFI) value, which was introduced previously as a quantitative parameter of the overall functionality of the T-cell response analysed [30] . The MFI values showed that the triple-positive T cells had the highest MFI values, followed by the doublecytokine-producing T cells, whereas single-positive T cells showed only minor MFI values (data not shown). However, when iMFI values were analyzed, the IFN-γ iMFI was the highest intensity within the IFN-γ + TNF-α + double-positive CD8 + T-cell population, followed by IFN-γ + singlecytokine-producing T cells ( Figure 3A) . This was also observed for TNF-α iMFI ( Figure 3B ). Taken together, these results indicate that double-and single-positive T cells contribute quantitatively more to the Mtb Rpf Rv0867c antigen response in long-term non-progressors than triple-positive T cells. 
Discussion
New TB vaccines are urgently needed to help control the TB pandemic. Both prophylactic and postexposure vaccines are considered important [33] , but the antigens that can best be incorporated in such vaccines have been identified incompletely at best. Previously we have shown that dormancy-related or DosR regulon-encoded Mtb antigens, which are expressed during hypoxia and nitric oxide stress, were preferentially recognized by TST-positive individuals, suggesting an association with control of infection [22;34;35] . Unexpectedly, BCG vaccination failed to induce responses to these antigens in humans and mice, even though BCG is able to express the DosR regulon under hypoxia conditions in vitro [26] . In contrast to the DosR regulon-encoded antigens, rpf genes Rv0867c and Rv2389c are expressed by actively replicating early log-phase-grown Mtb [4] . Rv0867c and Rv2389c share the M. luteus Rpf protein's property in being able to resuscitate dormant mycobacteria. We therefore hypothesized that immunity directed against these proteins may play a role in sensing and detecting actively resuscitating and replicating Mtb organisms and therefore possibly also in host immune control of reactivating bacteria.
We observed significant differences in levels of Rv0867c and Rv2389c recognition between mycobacterium-exposed vs. PPD-negative individuals, yet some Rv2389c and, to a lesser extent, Rv0867c responses were found in the healthy PPD-nonresponding group. We have previously reported a similar recognition pattern for some Mtb dosR regulon-encoded antigens by PPDnonresponding donors. We explained these results by cross-reactive immunity to nontuberculous mycobacteria (NTM) which share large parts of the DosR regulon with Mtb and M. bovis BCG [36] . Antigen contaminants (E.coli products) are less likely to be involved, since our recombinant proteins are standard quality control (QC) tested on cells from 4 to 5 PPD-negative donors and released only when no IFN-γ is produced. A BLAST search (http://www.ncbi.nlm.nih.gov/blast/) of the Mtb Rv0867c and Rv2389c Rpf protein sequences indeed showed protein sequence identity in several NTM and nonmycobacterial environmental bacteria ( Table 2 ). Part of the immunogenic peptides identified in our current study are indeed conserved in the identified protein sequences of the species shown in Table 2 (P5 41-60 of Rv0867c CE*GGNW*INT and P12 111-130 of Rv2389c TQG*GAWP*C), compatible with cross-reactivity at the polyclonal T-cell level.
To more precisely investigate the function and phenotype of Rv0867c-and Rv2389c specific T-cell subsets, we analyzed the presence of mono-and polyfunctional CD4 + and CD8 + T cells in PBMCs of latently infected individuals who had been infected decades ago without developing TB. In the Dutch cohort above, we had identified Rv2389c as the best-recognized antigen, whereas in the long-term Mtb nonprogressors Rv0867c induced higher frequencies of polyfunctional and single-positive T cells. This difference might be attributable to the type and/or longevity of the infection as Mtb is more likely to be chronic than NTM infections, and Mtb might be a stronger immunogen than NTM. Among the polyfunctional antigen-specific T cells present in the long-term nonprogressors, predominantly Rv0867c-specific CD8 + were identified, particularly double-producing IFN-γ + TNF-α + , Tem and Teff cells with high iMFI. This suggests that these two Rpf-specific CD8 + T-cell subsets may play a significant role in TB infection, next to triple-positive T cells. Of interest, IFN-γ + TNFα + double-positive CD8 + T cells were also found following vaccination with AERAS-402 vaccine, containing Ag85A, Ag85B, and TB10.4 antigens as a BCG boost, and these cells persisted over time [37] . Overall, CD8 + T cells are important in controlling Mtb infection, and the identification of prominent populations of Rv0867c-specific CD8 + T cells supports this notion. Nevertheless, relatively little is known about these antigen-specific polyfunctional CD8 + T cells and their role in protection [38] .
Rv0867c-specific, IFN-γ + TNF-α + double-cytokine-producing CD8 + T cells were mainly Tem and Teff cells. These high CD8 + Tem en Teff subset responses to Rv0867c in the long-term Mtb nonprogressors do not seem to correspond to the hypothesis that after clearance of infection Tem populations gradually wane, resulting mainly in long-lived Tcm cells [39] . A recent study showed that reexposure to antigens increased the number of CD8 + Tem cells. Our latently infected individuals may be continuously reexposed to Rpf antigens expressed by either endogenous uncleared Mtb organisms or by other environmental bacteria expressing cross-reactive Rpf-like antigens, which boost Rv0867c-specific Tem cells [40] . Regardless, Rv0867c Mtb Rpf antigen is recognized in long-term Mtb nonprogressors, indicating that Rpf-specific T-cell responses are maintained for decades after the initial Mtb infection. Of note, the immune system changes with aging. Fewer naïve T-cells will be available during aging as a result of thymic involution. However, CD8 + Tcm, Tem, and Teff cells accumulate with age [41;42] . These data are in agreement with our Tem and Teff findings in our elderly population (average age, 70 years).
Besides CD8 + T cells, also a minor proportion of polyfunctional CD4 + T cells was observed ( Figure 2E ). Although previous results have indicated that triple-positive polyfunctional CD4 + T cells can be induced by BCG vaccination, they are also clearly present in TB patients, such that they do not necessarily correlate with protection against developing disease [3] . Minor but significant proportions of triple-positive CD4 + polyfunctional T cells were identified in our work reported here.
We conclude that Mtb Rv0867c and Rv2389c Rpf antigens are immunogenic in humans, as evidenced by antigen-specific cytokine production and high frequencies and iMFI values. Both single-and double-cytokine-producing Rv0867c-specific CD4 + and CD8 + T cells were identified in long-term latently infected individuals who did not develop TB. By directing T-cell responses to Mtb Rpf antigens it may be possible to enhance immune surveillance of reactivating and resuscitating Mtb bacilli, and thereby help to control TB reactivation, which is the major complication in latent TB that keeps fuelling the TB pandemic. 
